FDA recall D-383-2014

Sandoz Incorporated · Class II · drug

Product

Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd. for Sandoz Inc., Princeton, NJ NDC 0781-2102-01

Reason for recall

Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2013-10-22
Report date
2014-01-01
Termination date
2014-07-10
Voluntary/Mandated
Voluntary: Firm initiated
Location
Broomfield, CO, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-383-2014